Noninvasive assessment of liver damage in chronic hepatitis B.
about
Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.Use of serum levels of proinflammatory cytokine IL-1alpha in chronic hepatitis B.Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?Aspartate aminotransferase to platelet ratio index - a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues.Role of the Aspartate Transaminase and Platelet Ratio Index in Assessing Hepatic Fibrosis and Liver Inflammation in Adolescent Patients with HBeAg-Positive Chronic Hepatitis B.
P2860
Noninvasive assessment of liver damage in chronic hepatitis B.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Noninvasive assessment of liver damage in chronic hepatitis B.
@en
Noninvasive assessment of liver damage in chronic hepatitis B.
@nl
type
label
Noninvasive assessment of liver damage in chronic hepatitis B.
@en
Noninvasive assessment of liver damage in chronic hepatitis B.
@nl
prefLabel
Noninvasive assessment of liver damage in chronic hepatitis B.
@en
Noninvasive assessment of liver damage in chronic hepatitis B.
@nl
P2093
P2860
P356
P1476
Noninvasive assessment of liver damage in chronic hepatitis B
@en
P2093
Alper Yurci
Gokmen Zararsız
Kadri Guven
Mehmet Yucesoy
Omer Ozbakır
Sebnem Gursoy
Serkan Dogan
P2860
P304
P356
10.4254/WJH.V5.I8.439
P577
2013-08-01T00:00:00Z